Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

The relation of circulating YKL-40 to levels and decline of lung function in adult life.

Guerra S, Halonen M, Sherrill DL, Venker C, Spangenberg A, Carsin AE, Tarès L, Lavi I, Barreiro E, Martínez-Moratalla J, Urrutia I, Sunyer J, Antó JM, Martinez FD.

Respir Med. 2013 Dec;107(12):1923-30. doi: 10.1016/j.rmed.2013.07.013. Epub 2013 Aug 3.

2.

Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study.

Guerra S, Halonen M, Vasquez MM, Spangenberg A, Stern DA, Morgan WJ, Wright AL, Lavi I, Tarès L, Carsin AE, Dobaño C, Barreiro E, Zock JP, Martínez-Moratalla J, Urrutia I, Sunyer J, Keidel D, Imboden M, Probst-Hensch N, Hallberg J, Melén E, Wickman M, Bousquet J, Belgrave DC, Simpson A, Custovic A, Antó JM, Martinez FD.

Lancet Respir Med. 2015 Aug;3(8):613-20. doi: 10.1016/S2213-2600(15)00196-4. Epub 2015 Jul 6.

3.

Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease.

Otsuka K, Matsumoto H, Niimi A, Muro S, Ito I, Takeda T, Terada K, Yamaguchi M, Matsuoka H, Jinnai M, Oguma T, Nakaji H, Inoue H, Tajiri T, Iwata T, Chin K, Mishima M.

Respiration. 2012;83(6):507-19. doi: 10.1159/000330840. Epub 2011 Sep 27.

4.

Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.

James AJ, Reinius LE, Verhoek M, Gomes A, Kupczyk M, Hammar U, Ono J, Ohta S, Izuhara K, Bel E, Kere J, Söderhäll C, Dahlén B, Boot RG, Dahlén SE; BIOAIR (Longitudinal Assessment of Clinical Course and Biomarkers in Severe Chronic Airway Disease) Consortium.

Am J Respir Crit Care Med. 2016 Jan 15;193(2):131-42. doi: 10.1164/rccm.201504-0760OC.

PMID:
26372680
5.

Lower FEV1 in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV1, total IgE levels, and TSLP genotypes.

Masuko H, Sakamoto T, Kaneko Y, Iijima H, Naito T, Noguchi E, Hirota T, Tamari M, Hizawa N.

Int J Chron Obstruct Pulmon Dis. 2011;6:181-9. doi: 10.2147/COPD.S16383. Epub 2011 Mar 2.

6.

YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages.

Létuvé S, Kozhich A, Arouche N, Grandsaigne M, Reed J, Dombret MC, Kiener PA, Aubier M, Coyle AJ, Pretolani M.

J Immunol. 2008 Oct 1;181(7):5167-73.

7.

Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD.

Sakazaki Y, Hoshino T, Takei S, Sawada M, Oda H, Takenaka S, Imaoka H, Matsunaga K, Ota T, Abe Y, Miki I, Fujimoto K, Kawayama T, Kato S, Aizawa H.

PLoS One. 2011;6(9):e24177. doi: 10.1371/journal.pone.0024177. Epub 2011 Sep 7.

8.

A chitinase-like protein in the lung and circulation of patients with severe asthma.

Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, Dziura JD, Reed J, Coyle AJ, Kiener P, Cullen M, Grandsaigne M, Dombret MC, Aubier M, Pretolani M, Elias JA.

N Engl J Med. 2007 Nov 15;357(20):2016-27.

9.

The chitinase-like protein YKL-40 is not a useful biomarker for severe persistent asthma in children.

Santos CB, Davidson J, Covar RA, Spahn JD.

Ann Allergy Asthma Immunol. 2014 Sep;113(3):263-6. doi: 10.1016/j.anai.2014.05.024. Epub 2014 Jun 20.

PMID:
24954373
10.

Impact of Birth Weight and Smoking on Lung Function in Patients with Asthma, COPD, and Healthy Volunteers.

Panaszek B, Pawłowicz R, Lindner K, Dobek R, Panaszek K, Obojski A, Rosińczuk J, Ichnowski J.

Adv Clin Exp Med. 2016 Nov-Dec;25(6):1207-1213. doi: 10.17219/acem/62455.

11.

YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment.

Lai T, Chen M, Deng Z, L Y, Wu D, Li D, Wu B.

BMC Pulm Med. 2015 Jan 12;15:1. doi: 10.1186/1471-2466-15-1.

12.

Symptoms and lung function decline in a middle-aged cohort of males and females in Australia.

Abramson MJ, Kaushik S, Benke GP, Borg BM, Smith CL, Dharmage SC, Thompson BR.

Int J Chron Obstruct Pulmon Dis. 2016 May 26;11:1097-103. doi: 10.2147/COPD.S103817. eCollection 2016.

13.

High serum YKL-40 level in patients with COPD is related to hypoxemia and disease severity.

Gumus A, Kayhan S, Cinarka H, Kirbas A, Bulmus N, Yavuz A, Sahin U, Ozkaya S.

Tohoku J Exp Med. 2013 Feb;229(2):163-70.

14.

Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease.

Holmgaard DB, Mygind LH, Titlestad IL, Madsen H, Pedersen SS, Johansen JS, Pedersen C.

BMC Pulm Med. 2013 Dec 30;13:77. doi: 10.1186/1471-2466-13-77.

15.

Early life origins of chronic obstructive pulmonary disease.

Svanes C, Sunyer J, Plana E, Dharmage S, Heinrich J, Jarvis D, de Marco R, Norbäck D, Raherison C, Villani S, Wjst M, Svanes K, Antó JM.

Thorax. 2010 Jan;65(1):14-20. doi: 10.1136/thx.2008.112136. Epub 2009 Sep 2.

PMID:
19729360
16.

Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study.

Caramori G, Fabbri M, Paioli D, Falcone F, Severino C, Felisatti G, Arar O, Adcock IM, Fan Chung K, Barnes PJ, Ciaccia A, Papi A.

Monaldi Arch Chest Dis. 2005 Jun;63(2):84-7.

PMID:
16128222
17.
18.

Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.

Thomsen M, Nordestgaard BG, Vestbo J, Lange P.

Lancet Respir Med. 2013 Sep;1(7):543-50. doi: 10.1016/S2213-2600(13)70137-1. Epub 2013 Jul 29.

PMID:
24461615
19.

Childhood-onset asthma in smokers. association between CT measures of airway size, lung function, and chronic airflow obstruction.

Diaz AA, Hardin ME, Come CE, San José Estépar R, Ross JC, Kurugol S, Okajima Y, Han MK, Kim V, Ramsdell J, Silverman EK, Crapo JD, Lynch DA, Make B, Barr RG, Hersh CP, Washko GR; COPDGene Investigators.

Ann Am Thorac Soc. 2014 Nov;11(9):1371-8. doi: 10.1513/AnnalsATS.201403-095OC.

20.

Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.

Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM.

Am J Respir Crit Care Med. 2007 Mar 1;175(5):458-63. Epub 2006 Dec 7.

PMID:
17158282

Supplemental Content

Support Center